EDESA BIOTECH, INC. (EDSA) Operating income 2016–2025
EDESA BIOTECH, INC. (EDSA) annual operating income history from SEC filings — each fiscal year as reported.
-$7.9MFY2025 · since FY2016: -$4.9M → -$7.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.9M | -12.8% |
| FY2024 | -$7.0M | +23.9% |
| FY2023 | -$9.2M | +49.8% |
| FY2022 | -$18.4M | +22.4% |
| FY2021 | -$23.7M | -270.0% |
| FY2020 | -$6.4M | — |
| FY2018 | -$1.6M | +69.0% |
| FY2017 | -$5.2M | -6.4% |
| FY2016 | -$4.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More EDSA financial trends
EDSA RevenueEDSA Net incomeEDSA Net marginEDSA Gross profitEDSA Gross marginEDSA Operating marginEDSA Operating cash flowEDSA Free cash flowEDSA Capital expendituresEDSA Return on equityEDSA Stock buybacksEDSA Dividends paidEDSA Total assetsEDSA Total liabilitiesEDSA Shareholders’ equityEDSA overview →